Donenko F V, Chikvashvili B Sh, Borovkova N B, Devichenskiĭ V M, Kabieva A O, Korneva E N, Telegin L Iu, Shcherbakov V M, Letiagin V P, Moroz L V
Biull Eksp Biol Med. 1991 Mar;111(3):300-2.
Phynoptin (Ph) and cyclophosphamide (CP) gave rise to a type I spectral changes with liver microsomal fraction. KS were 15 microM and 2150 microM, respectively. Ph increases the concentration of NBP product(s) of CP and acrolein in the blood plasma of animals. Ph increases a toxicity of CP. LD50 was 388.0 +/- 13.9 mg/kg for CP and LD50 was 342.8 +/- 16.9 mg/kg for CP in combination with Ph. Ph changes a therapeutic action of CP in mice with hemocytoblastosis La. Pharmacokinetic interactions have been demonstrated between calcium antagonists Ph and CP.
菲诺普汀(Ph)和环磷酰胺(CP)与肝微粒体部分产生了I型光谱变化。KS分别为15微摩尔和2150微摩尔。Ph增加了动物血浆中CP和丙烯醛的NBP产物浓度。Ph增加了CP的毒性。CP的半数致死量为388.0±13.9毫克/千克,CP与Ph联合使用时的半数致死量为342.8±16.9毫克/千克。Ph改变了CP对患有造血母细胞增多症La的小鼠的治疗作用。已证明钙拮抗剂Ph和CP之间存在药代动力学相互作用。